Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 19, 2013

Primary Completion Date

June 1, 2017

Study Completion Date

February 28, 2018

Conditions
Invasive Fungal DiseaseChronic Disseminated CandidiasisHematological MalignanciesHematopoietic Stem Cell TransplantationNeutropenia
Interventions
DEVICE

18F-FDG PET Scan

to determine whether F18 fluorodeoxyglucose (18F-FDG) positron-emission tomography scan (PET scan) is useful for the therapy strategy of hepatosplenic candidiasis.

Trial Locations (1)

75015

Service des Maladies Infectieuses et Tropicales - Centre d'Infectiologie Necker-Pasteur, IHU Imagine - Hôpital Necker-Enfants Malades,, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Lausanne Hospitals

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01916057 - Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis | Biotech Hunter | Biotech Hunter